Use fundamental data analysis to double-check all available reported financial drivers of CVS Health to find out if markets are now mispricing the company. We found thirty-eight available fundamental indicators for CVS Health Corporation which can be compared to its rivals. To make sure the equity is not overpriced, please confirm all CVS Health fundamentals including its Revenue, Cash Flow from Operations, Current Asset, as well as the relationship between Cash per Share and Beta . Given that CVS Health has Price to Earning of 10.19 times, we suggest you validate CVS Health Corporation prevailing market performance to make sure the company can sustain itself next year.Use CVS Health to enhance returns of your portfolios. The stock experiences large bullish trend. Check odds of CVS Health to be traded at $69.99 in 30 days
CVS Health Valuation Over Time
CVS Health Company SummaryCVS Health competes with Laboratory of, MEDNAX, Envision Healthcare, Concord Medical, and CENTENE CORP. CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. CVS Health Corporation was founded in 1892 and is headquartered in Woonsocket, Rhode Island. CVS Health operates under Health Care Plans classification in USA and traded on New York Stock Exchange. It employs 160000 people.
CVS Health Z Score vs Beta
CVS Health Corporation is rated fourth in z score category among related companies. It is rated fourth in beta category among related companies totaling about 0.39 of Beta per Z Score. The ratio of Z Score to Beta for CVS Health Corporation is roughly 2.59